RIV Capital Inc.

RIV

CA7680141024

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 12:33:41 2024-04-26 pm EDT			5-day change	1st Jan Change
0.11 ^CAD	+4.76%		+10.00%	+4.76%

Feb. 14	RIV Capital Reports Opening of Adult-Use Dispensary in White Plains, New York, by Etain	MT
2023	RIV Capital Up 13.6% After Reporting Approval for Etain to Start Sales to Adult-Use Market in New YorK	MT

RIV Capital Inc.'s Equity Buyback announced on February 24, 2023, has expired with 33,733,334 shares, for CAD 19.63 million.

March 30, 2023

The company expired its plan in fourth quarter of 2023.

Latest news about RIV Capital Inc.

RIV Capital Reports Opening of Adult-Use Dispensary in White Plains, New York, by Etain	Feb. 14	MT
RIV Capital Up 13.6% After Reporting Approval for Etain to Start Sales to Adult-Use Market in New YorK	Dec. 08	MT
RIV Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 29	CI
Transcript : RIV Capital Inc., Q2 2024 Pre Recorded Earnings Call, Nov 29, 2023	Nov. 28
RIV Capital Inc. Completes Expansion of New York Cultivation and Production Operations	Nov. 07	CI
Transcript : RIV Capital Inc., Q1 2024 Pre Recorded Earnings Call, Aug 28, 2023	23-08-27
RIV Capital Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-27	CI
RIV Capital's Fiscal Q4 Loss Widens; Provides Corporate Update	23-06-15	MT
Tranche Update on RIV Capital Inc.'s Equity Buyback Plan announced on February 24, 2023.	23-06-13	CI
Transcript : RIV Capital Inc., Q4 2023 Earnings Call, Jun 14, 2023	23-06-13
RIV Capital Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-13	CI
RIV Capital Inc.'s Equity Buyback announced on February 24, 2023, has expired with 33,733,334 shares, for CAD 19.63 million.	23-03-30	CI
RIV Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-03-01	CI
Transcript : RIV Capital Inc., Q3 2023 Pre Recorded Earnings Call, Mar 01, 2023	23-02-28
JW Asset Management Enters into Settlement Agreement with RIV Capital	23-02-24	CI
RIV Capital Inc. announces an Equity Buyback for 33,733,334 shares, representing 19.95% for $19.63 million.	23-02-24	CI
RIV Capital Inc. authorizes a Buyback Plan.	23-02-22	CI
RIV Capital Schedules Special Meeting of Shareholders in Response to Shareholder Requisition	23-01-09	CI
RIV Capital Acknowledges Receipt of Shareholder Meeting Requisition by JW Asset Management	22-12-22	CI
JW Asset Management Seeks Replacement of Directors at RIV Capital	22-12-20	CI
RIV Capital Inc. Brief: Largest Shareholder Also Adds "Transactions with related parties and lack of independent oversight need to be addressed for Company to be successful over time"	22-12-20	MT
RIV Capital Inc. Brief: Largest Shareholder Adds "Current leadership team recklessly pursued and closed on overpriced and risky acquisition without shareholder vote or fairness opinion"	22-12-20	MT
RIV Capital Inc. Brief: Says "Immediate Board refresh is needed to preserve shareholder value and maximize the Company's potential"	22-12-20	MT
RIV Capital Inc. Brief: Says Largest Shareholder, JW Asset Management, Requisitions Special Meeting to Address Necessary Leadership Changes	22-12-20	MT
RIV Capital Inc. Announces Removal of Board of Directors	22-12-20	CI

RIV Capital Inc. is a Canada-based acquisition and investment company. The Company is focused on the United States (U.S.) cannabis market by acquiring, investing in, and developing operators and brands to create a multistate platform. The Company is a direct parent company of RIV Capital US Corporation and RIV Capital Corporation and exercises financial control over Etain, LLC. Through its strategic relationship with The Hawthorne Collective, Inc. (The Hawthorne Collective), a subsidiary of The ScottsMiracle-Gro Company (ScottsMiracle-Gro), the Company is The Hawthorne Collective's preferred vehicle for cannabis-related investments not under the purview of other ScottsMiracle-Gro subsidiaries. The Company's subsidiaries include 2683922 Ontario Inc., RIV Capital US Corporation, RIV Capital US Holdings LLC, RIV Capital US Real Estate LLC and RIV Capital US Services LLC.

Sector

Pharmaceuticals

Calendar

2024-04-28 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
RIV CAPITAL INC.	+4.76%	10.91M
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B